Interestingly, the expression of ALDH1A1 and PON1 was significantly higher in NAT than in TN (P < 0.01), suggesting a higher proportion of cancer cells with stem cell properties in the residual tumors following NAT compared with TN tumors. The gene discussed is BRD2; the disease is cancer.